Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
283 studies found for:    Open Studies | "Carcinoma, Renal Cell"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Renal Cell"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
Condition: Carcinoma, Renal Cell
Interventions: Drug: Sunitinib;   Drug: Temsirolimus;   Drug: Sorafenib;   Drug: Pazopanib;   Drug: Everolimus;   Drug: Axitinib
2 Recruiting Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)
Condition: Carcinoma, Renal Cell
Interventions: Drug: Pazopanib;   Drug: MK-3475
3 Recruiting Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Drug: Pazopanib;   Other: Low Fat Diet
4 Recruiting PII SBRT + Microwave Ablation in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT);   Procedure: Microwave Ablation (MWA)
5 Recruiting Intraoperative Dual-modality Imaging in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Drug: Indium-111-DOTA-Girentuximab-IRDye800CW;   Radiation: SPECT/CT;   Procedure: Intraoperative dual-modality imaging
6 Recruiting Glycosaminoglycan Scores as Predictive Biomarkers in Confined Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention:
7 Recruiting Glycosaminoglycan Scores as Predictive Biomarkers in Advanced Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention:
8 Recruiting Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.
Condition: Carcinoma, Renal Cell
Intervention: Radiation: Stereotactic body radiotherapy
9 Not yet recruiting Pazopanib Vs. Local Therapy for Renal Cancer With Metastases
Condition: Carcinoma, Renal Cell
Interventions: Radiation: Radiation;   Drug: Pazopanib
10 Recruiting A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)
Condition: Renal Cell Cancer
Interventions: Drug: Avelumab (MSB0010718C);   Drug: Axitinib (AG-013736)
11 Recruiting Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Conditions: Carcinoma, Renal Cell;   Clear Cell Renal Cell Carcinoma
Intervention: Drug: axitinib
12 Recruiting Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell;   Clear-cell Metastatic Renal Cell Carcinoma
Intervention: Biological: Nivolumab/Ipilimumab
13 Recruiting Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer
Condition: Renal Cancers
Intervention: Radiation: Stereotactic Ablative Radiation Therapy
14 Recruiting Stereotactic Radiotherapy for Renal Cancers
Condition: Renal Cancer
Interventions: Radiation: Stereotactic radiotherapy 4 x 8 Gy;   Radiation: Stereotactic radiotherapy 5 x 8 Gy;   Radiation: Stereotactic radiotherapy 4 x 10 Gy;   Radiation: Stereotactic radiotherapy 4 x 12 Gy
15 Not yet recruiting A Study Combining NeoVax, a Personalized NeoAntigen Cancer Vaccine, With Ipilimumab to Treat High-risk Renal Cell Carcinoma
Condition: Kidney Cancer
Interventions: Drug: NeoVax;   Drug: Ipilimumab
16 Recruiting Kidney Cancer DNA Registry
Condition: Renal Cancer
Interventions: Other: salvia for germline DNA;   Behavioral: the Kidney Cancer Questionnaire;   Behavioral: Family History Questionnaire (when applicable)
17 Recruiting High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer
Condition: Metastatic Clear Cell Renal Cell Carcinoma
Interventions: Drug: IL-2;   Radiation: Stereotactic Ablative Body Radiation Therapy
18 Recruiting A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Device: CyberKnife
19 Recruiting A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Condition: Renal Cell Cancer
Interventions: Drug: Avelumab (MSB0010718C);   Drug: Axitinib (AG-013736);   Drug: Sunitinib
20 Recruiting Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
Condition: Metastatic Renal Cell Cancer
Interventions: Drug: RX-0201;   Drug: Everolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.